Scholarlink

<p>Copper overload induces cuproptosis, a unique mitochondria regulated cell death distinct from apoptosis, pyroptosis and ferroptosis. Cuproptosis is involved in cancer progression, drug resistance and immune microenvironment remodeling, making it a promising target for cancer intervention. Key regulators including Copper Transport Protein 1 (CTR1) and Ferredoxin 1 (FDX1) serve as predictive biomarkers: high FDX1 expression indicates enhanced sensitivity to cuproptosis inducers and favorable prognosis in non-small cell lung cancer, supporting precise risk stratification under the Predictive, Preventive and Personalized Medicine(3PM) framework. This review summarizes the molecular mechanisms of cuproptosis and its multifaceted roles in cancer within Predictive, Preventive and Personalized Medicine. Curcumin exhibits potential in modulating cuproptosis homeostasis for high-risk populations with copper overload or precancerous lesions, providing a feasible preventive strategy. We also discuss cuproptosis-targeted therapies, combination regimens and the value of traditional Chinese medicine, while clarifying crosstalk with other cell death pathways. This review addresses the clinical gap of lacking effective predictive and preventive targets for precision oncology, offering novel 3PM-oriented insights for cancer diagnosis, prevention and treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cuproptosis: a novel mechanism and 3PM-oriented therapeutic strategy for cancer

  • 期刊论文

  • 发表日期：

    2026年5月18日

查看全文
  • Ding Yang,
  • Wei-Ting Hu,
  • Miao Li,
  • Fang-Qing Shen,
  • Hao-Yu Wang,
  • Jin-Ying Ye,
  • Fu-Lu Ren,
  • Yun Wang

摘要

Copper overload induces cuproptosis, a unique mitochondria regulated cell death distinct from apoptosis, pyroptosis and ferroptosis. Cuproptosis is involved in cancer progression, drug resistance and immune microenvironment remodeling, making it a promising target for cancer intervention. Key regulators including Copper Transport Protein 1 (CTR1) and Ferredoxin 1 (FDX1) serve as predictive biomarkers: high FDX1 expression indicates enhanced sensitivity to cuproptosis inducers and favorable prognosis in non-small cell lung cancer, supporting precise risk stratification under the Predictive, Preventive and Personalized Medicine(3PM) framework. This review summarizes the molecular mechanisms of cuproptosis and its multifaceted roles in cancer within Predictive, Preventive and Personalized Medicine. Curcumin exhibits potential in modulating cuproptosis homeostasis for high-risk populations with copper overload or precancerous lesions, providing a feasible preventive strategy. We also discuss cuproptosis-targeted therapies, combination regimens and the value of traditional Chinese medicine, while clarifying crosstalk with other cell death pathways. This review addresses the clinical gap of lacking effective predictive and preventive targets for precision oncology, offering novel 3PM-oriented insights for cancer diagnosis, prevention and treatment.